WASHINGTON — Independent presidential candidate Robert F. Kennedy Jr. began a marathon congressional testimony session Tuesday, facing intense scrutiny over his record on public health issues while attempting to avoid reigniting controversies about his long-standing skepticism of vaccines.
The environmental lawyer turned politician, who recently won several state primaries under his newly formed MAHA (Make America Healthy Again) party, is expected to highlight his advocacy work on clean water and corporate pollution during the hearings. However, analysts suggest committee members will likely press him on his vaccine misinformation history, which public health experts have repeatedly discredited.
“He’s walking a political tightrope,” said one Capitol Hill staffer familiar with the proceedings, speaking anonymously because they weren’t authorized to discuss the hearings publicly. “The MAHA victories give him credibility with certain voters, but his vaccine rhetoric remains radioactive in mainstream health circles.”
Kennedy’s testimony comes as Congress debates reauthorization of the Pandemic and All-Hazards Preparedness Act, legislation that includes vaccine research funding. His appearance before multiple committees marks an unusual moment where a presidential candidate simultaneously faces legislative questioning during an active campaign.
Public health advocates have warned that Kennedy’s testimony could provide a platform for anti-vaccine messaging. “This hearing risks legitimizing dangerous pseudoscience,” said Dr. Alicia Chang, an epidemiologist quoted in STAT’s coverage of the event. Meanwhile, Kennedy’s supporters argue he’s being unfairly targeted for challenging pharmaceutical industry practices.
The outcome of these hearings could significantly impact Kennedy’s ability to gain ballot access in additional states and shape how his public health record is framed during the general election campaign.